Polyphenol nanocomplex modulates lactate metabolic reprogramming and elicits immune responses to enhance cancer therapeutic effect
- Drug Resist Updat. 2024 Mar:73:101060. doi: 10.1016/j.drup.2024.101060.
- 1. Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China; Cancer Stem Cell and Translational Medicine Laboratory, Shengjing Hospital of China Medical University, Shenyang, China; Innovative Cancer Drug Research and Development Engineering Center of Liaoning Province, Shenyang, China.
- 2. Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
- 3. Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China; Cancer Stem Cell and Translational Medicine Laboratory, Shengjing Hospital of China Medical University, Shenyang, China; Innovative Cancer Drug Research and Development Engineering Center of Liaoning Province, Shenyang, China. Electronic address: [email protected].
Cancer lactate metabolic reprogramming induces an elevated level of extracellular lactate and H+, leading to an acidic immunosuppressive tumor microenvironment (TEM). High lactic acid level may affect the metabolic programs of various cells that comprise an antitumor immune response, therefore, restricting immune-mediated tumor destruction, and leading to therapeutic resistance and unsatisfactory prognosis. Here, we report a metal-phenolic coordination-based nanocomplex loaded with a natural polyphenol galloflavin, which inhibits the function of Lactate Dehydrogenase, reducing the production of lactic acid, and alleviating the acidic immunosuppressive TME. Besides, the co-entrapped natural polyphenol carnosic acid and the synthetic PEG-Ce6 polyphenol derivative (serving as a Photosensitizer) could induce immunogenic Cancer cell death upon laser irradiation, which further activates immune system and promotes immune cell recruitment and infiltration in tumor tissues. We demonstrated that this nanocomplex-based combinational therapy could reshape the TME and elicit immune responses in a murine breast Cancer model, which provides a promising strategy to enhance the therapeutic efficiency of drug-resistant breast Cancer.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Lactate DehydrogenaseResearch Areas: Cancer